Macular telangiectasia type 2

Macular telangiectasia is a neurodegenerative disease of the macula that affects both eyes and causes loss of central vision. Type 2 is the most common, although its prevalence in the population is 0.12%.

Macular telangiectasia type 2 is a rare retinal disease that is not yet well characterized. It involves the dilation of the retinal capillaries in the macula, which can be primary or secondary, associated with other vascular pathologies.

This condition is more common in middle-aged adults, and both men and women are equally affected. It is a relatively unknown disease, although it has been associated with some conditions such as diabetes or hypertension.

Symptoms

In the early stages of the disease, no symptoms are present. As it progresses, visual problems such as blurred vision, distorted vision, and loss of central vision may occur. Generally, peripheral vision is not affected, and it does not cause total blindness. This loss is progressive and can be experienced over the years.

Prevention

The causes that lead to the appearance of macular telangiectasia type 2 are unknown, and therefore no preventive measures have been identified for its occurrence.

Currently, the disease has a relatively good prognosis as there are treatments that significantly improve vision in affected individuals. Thus, since it initially presents no symptoms, early diagnosis of the disease can greatly help limit its progression.

Additionally, it may sometimes be associated with other conditions such as diabetes or hypertension, so good control of these can reduce the risk in these patients.

Number of observed variants

13.5 million variants

Number of risk loci

10 loci

Genes analyzed

CPS1 EOMES FBN3 HMGCS2 JMJD1C PSPH SLC1A4 SLC6A20 TMEM161B TTC39B

Bibliography

Bayón-Porras R.M. et al. Telangiectasias maculares idiopáticas de tipo 2: prevalencia en nuestra área y estudio morfométrico y fenotípico. Archivos de la Sociedad Española de Oftalmología. 2018;93(3): 105-112.

Macular telangiectasia. American Academy of Ophthalmology [Apr 2023].

Bonelli R, Jackson VE, Prasad A, et al. Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder.

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy